Emtricitabine

Emtriva

Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor

NADAC/unit $14.5100

No Shortage Tier 1: 38.0% 2 Manufacturers 2 ANDAs

Emtricitabine blocks HIV replication by inhibiting reverse transcriptase.

vs. brand Emtriva: Generic saves up to -45% per unit

Covered Lives

Generic Manufacturers

AUROBINDO PHARMA LTDCIPLA LTDGILEAD SCIENCES INC

Explore in the Ecosystem

rxsaver.aiCompare prices for Emtricitabine drfinder.aiFind doctors who prescribe Emtricitabine clinicalrx.aiClinical profile: Emtricitabine rxnews.aiLatest news about Emtricitabine

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.